©The Author(s) 2026.
World J Gastroenterol. Jan 28, 2026; 32(4): 114420
Published online Jan 28, 2026. doi: 10.3748/wjg.v32.i4.114420
Published online Jan 28, 2026. doi: 10.3748/wjg.v32.i4.114420
Figure 11 The expression level of related mechanism protein.
A: Western blots showing the levels of Janus kinase 1, p-signal transducer and activator of transcription 3, phosphoinositide 3-kinase, p-phosphoinositide 3-kinase, protein kinase B, p-protein kinase B, mammalian target of rapamycin, and p-mammalian target of rapamycin; B: The expression of each protein normalized by β-actin according to grey value. aP < 0.05. TP: Triptolide; QU: Quercetin; Jak1: Janus kinase 1; Stat3: Signal transducer and activator of transcription 3; PI3K: Phosphoinositide 3-kinase; AKT: Protein kinase B; mTOR: Mammalian target of rapamycin.
- Citation: Tong HX, Zhang JL, Nie WY, Jiang LJ, Hu JQ, Lu T. Synergistic anti-hepatoma effect of triptolide and quercetin via co-inhibition and interaction with Janus kinase and mammalian target of rapamycin signal pathway. World J Gastroenterol 2026; 32(4): 114420
- URL: https://www.wjgnet.com/1007-9327/full/v32/i4/114420.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i4.114420